Therapeutic gas for the treatment of mitochondrial disorders
US10117893B2 · kind B2 · utility
0Cited by
2References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 27, 2010 |
| Grant date | Nov 6, 2018 |
| Priority date | — |
| Expiry date | Dec 25, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2230/205
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of gaseous oxygen for the production of a therapeutic gas for inhalation by a patient who has been identified as a person with a mitochondrial disorder or a coenzyme Q10 deficiency, for the treatment of mitochondrial disorders or Q10 deficiencies is disclosed.For the first time a non-invasive method is disclosed, upon what the body's own level of Q10 can be raised significantly without further interventions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.